Skip to content

When Is Prednisone Used for Sjögren's Syndrome Flares?

Published: | Updated:

Prednisone is not used to treat daily Sjögren's syndrome symptoms like dry eyes or dry mouth. Instead, rheumatologists prescribe it as a short-term bridge therapy to quickly control dangerous, active inflammation in major organs like the lungs or kidneys during severe flare-ups.

Key Takeaways

  • Prednisone is not recommended or effective for managing daily Sjögren's syndrome symptoms like dry eyes and dry mouth.
  • Systemic steroids are reserved for treating severe disease flare-ups that affect major organs, such as the lungs, kidneys, or blood vessels.
  • Doctors often use prednisone as a short-term bridge to rapidly control inflammation while waiting for long-term immunosuppressive medications to take effect.
  • Extended use of systemic steroids carries significant risks, including bone density loss, elevated blood sugar, and cardiovascular issues.
  • You should never stop taking a prescribed course of prednisone abruptly, as it requires a careful tapering schedule guided by your doctor.

If you have just been diagnosed with primary Sjögren’s syndrome, you might be worried that you will automatically be placed on systemic corticosteroids like prednisone (a strong anti-inflammatory medication). The short answer is no. Most patients with Sjögren’s syndrome do not need to take prednisone for their daily management [1]. Corticosteroids are not used to treat chronic dryness, but they are occasionally used in targeted, short-term ways to quickly control severe inflammation or organ-threatening complications [1][2].

Understanding exactly when, how, and why your rheumatologist might suggest prednisone can help you prepare for these conversations and protect your long-term health.

Why Prednisone is Not Used for Dryness

The hallmark symptoms of Sjögren’s syndrome—dry eyes, dry mouth, and generalized fatigue—are known as sicca symptoms. Medical guidelines strongly recommend against using systemic corticosteroids for the long-term management of these daily symptoms [3][1][4].

There are two main reasons for this:

  • Lack of Benefit: Research shows that prednisone does not actually improve the function of your salivary (saliva) or lacrimal (tear) glands [3].
  • High Risk of Side Effects: Taking systemic steroids long-term carries significant risks that outweigh any potential benefits for dryness. These risks include an increased chance of cardiovascular disease [4], weight gain, and loss of bone density [1].

Current medical consensus focuses on managing dryness with targeted local therapies (like prescription eye drops and saliva stimulators) instead of using system-wide immune suppression [5][6]. For daily systemic symptoms like generalized fatigue and mild joint pain, many rheumatologists rely on foundational medications like hydroxychloroquine (Plaquenil) instead of steroids.

When is Prednisone Actually Prescribed?

While not used for dryness, prednisone is an incredibly effective tool for shutting down dangerous, active inflammation. In Sjögren’s syndrome, about 30-40% of patients develop extraglandular manifestations—meaning the immune system attacks areas outside of the moisture-producing glands [1].

Prednisone is typically reserved for these severe, systemic complications, which may include:

  • Vasculitis: Inflammation of the blood vessels, which can cause skin rashes or nerve damage [1].
  • Interstitial Lung Disease (ILD): Inflammation and scarring in the lungs that causes shortness of breath [1][2].
  • Severe Joint Inflammation: Intense, active swelling in the joints that mimics rheumatoid arthritis [1].
  • Other Major Organ Involvement: Significant inflammation affecting the kidneys or nervous system [7][8].

Because there are no large-scale clinical trials establishing strict rules just for Sjögren’s, doctors often borrow treatment strategies from guidelines for other autoimmune diseases like systemic lupus erythematosus (SLE) when treating these severe complications [1][2].

How Prednisone is Used (The Treatment Strategy)

If you develop a severe systemic flare, the goal of using prednisone is to gain control of the disease as quickly as possible. However, the ultimate strategy is always to get you back off the steroids.

  • The “Bridge” Approach: Prednisone acts very fast. It is often prescribed to immediately cool down a severe flare-up while you wait for slower-acting, long-term immunosuppressive drugs (like methotrexate, azathioprine, or mycophenolate) to build up in your system [1][9]. This “bridge” period usually lasts for a few weeks to a few months, depending on how quickly your long-term medications take effect.
  • Individualized Dosing: There is no standard “Sjögren’s dose” for prednisone [1][6]. The amount you take will depend entirely on which organ is affected and how severe the inflammation is.
  • Tapering: Once the inflammation is under control and your long-term medications are working, your doctor will slowly reduce (taper) your prednisone dose [1][10]. Never stop taking prednisone abruptly without your doctor’s explicit guidance. Stopping systemic steroids suddenly can cause a life-threatening condition called an adrenal crisis.

Managing Your Anxiety About Side Effects

It is completely normal to feel anxious if your doctor suggests starting prednisone. The type and intensity of side effects are often dose-dependent, meaning they are more likely to occur at higher doses or over longer periods of time [6].

  • Short-Term Side Effects: In the first few days of a “bridge” therapy, you might experience insomnia, jitteriness, and a sudden increase in appetite.
  • Long-Term Side Effects: Extended use increases the risk of weight gain, mood changes, elevated blood sugar (hyperglycemia, which is critical to monitor if you have prediabetes or diabetes), increased susceptibility to infections, and bone density loss [1].

Bone health is an especially important topic, as patients with primary Sjögren’s syndrome naturally have a higher risk of fragility fractures even without taking steroids [11]. If you and your doctor decide that a short course of prednisone is necessary to protect your organs, you can take proactive steps:

  • Protect Your Bones: Discuss strategies for preventing bone loss. Clinical practice heavily favors starting bone protection protocols (like calcium, vitamin D, and sometimes prescription bone medications) alongside steroid use [1][12].
  • Request a Baseline DEXA Scan: A DEXA scan measures your bone mineral density. Getting one before or shortly after starting steroids gives your care team a baseline to monitor your bone health [11].
  • Communicate: Let your doctor know immediately if you experience severe mood changes, sleep disruptions, signs of infection, or significant fluid retention.

Frequently Asked Questions

Is prednisone used to treat dry eyes and dry mouth in Sjögren's syndrome?
No, medical guidelines strongly recommend against using systemic corticosteroids like prednisone for daily dryness. Research shows it does not improve salivary or tear gland function and carries high risks of long-term side effects.
When do rheumatologists prescribe prednisone for Sjögren's syndrome?
Prednisone is typically reserved for severe, systemic flare-ups where the immune system attacks areas outside the moisture glands. This includes dangerous inflammation in the blood vessels, lungs, kidneys, or severe joint swelling.
What does it mean to use prednisone as a bridge therapy?
A bridge approach uses fast-acting prednisone to quickly cool down a severe flare-up while you wait for slower-acting, long-term immunosuppressive medications to build up in your system. Once the long-term medication works, the prednisone is slowly tapered off.
Can I stop taking prednisone once my Sjögren's symptoms improve?
No, you should never stop taking prednisone abruptly without your doctor's explicit guidance. Stopping systemic steroids suddenly can cause a life-threatening condition called an adrenal crisis. Your doctor will provide a specific schedule to safely taper your dose.
How can I protect my bones if I need a course of prednisone?
You can protect your bones by discussing bone protection protocols with your doctor, such as taking calcium, vitamin D, or prescription bone medications. Getting a baseline DEXA scan before or shortly after starting steroids is also highly recommended to monitor your bone density.

Questions for Your Doctor

  • Under what specific circumstances would you consider prescribing prednisone for my Sjögren's syndrome?
  • If I develop a flare that requires steroids, what long-term medication will we use as a steroid-sparing agent to get me back off them?
  • Given my personal medical history, what proactive steps should we take to protect my bone density if I ever need a course of prednisone?
  • How do we differentiate between a normal fluctuation in my daily Sjögren's symptoms and a systemic flare that might require stronger medication?
  • If I am prescribed a steroid 'bridge,' roughly how long do you anticipate I will need to be on it before we begin tapering?

Questions for You

  • What are my primary concerns or fears regarding corticosteroid medications, and have I discussed them openly with my rheumatologist?
  • Have I experienced any new or unusual symptoms outside of my normal dryness and fatigue, such as shortness of breath, unexplained rashes, or severe joint swelling?
  • Am I currently taking any supplements or engaging in lifestyle habits (like weight-bearing exercises) that support my bone health?
  • Do I have a history of prediabetes or high blood sugar that I need to monitor if I start taking prednisone?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Primary Sjögren's Syndrome.

    Mariette X, Criswell LA

    The New England journal of medicine 2018; (378(10)):931-939 doi:10.1056/NEJMcp1702514.

    PMID: 29514034
  2. 2

    Current State of Knowledge on Primary Sjögren's Syndrome, an Autoimmune Exocrinopathy.

    Parisis D, Chivasso C, Perret J, et al.

    Journal of clinical medicine 2020; (9(7)) doi:10.3390/jcm9072299.

    PMID: 32698400
  3. 3

    Meta-Analysis of Treatment for Primary Sjögren's Syndrome.

    Chu LL, Cui K, Pope JE

    Arthritis care & research 2020; (72(7)):1011-1021 doi:10.1002/acr.23917.

    PMID: 31058469
  4. 4

    Increased risk of coronary heart disease among patients with primary Sjögren's syndrome: a nationwide population-based cohort study.

    Wu XF, Huang JY, Chiou JY, et al.

    Scientific reports 2018; (8(1)):2209 doi:10.1038/s41598-018-19580-y.

    PMID: 29396489
  5. 5

    Targeting primary Sjögren's syndrome.

    Odani T, Chiorini JA

    Modern rheumatology 2019; (29(1)):70-86 doi:10.1080/14397595.2018.1546268.

    PMID: 30424703
  6. 6

    Treatment Guidelines for Rheumatologic Manifestations of Sjögren's Syndrome: Use of Biologic Agents, Management of Fatigue, and Inflammatory Musculoskeletal Pain.

    Carsons SE, Vivino FB, Parke A, et al.

    Arthritis care & research 2017; (69(4)):517-527 doi:10.1002/acr.22968.

    PMID: 27390247
  7. 7

    Consensus Guidelines for Evaluation and Management of Pulmonary Disease in Sjögren's.

    Lee AS, Scofield RH, Hammitt KM, et al.

    Chest 2021; (159(2)):683-698 doi:10.1016/j.chest.2020.10.011.

    PMID: 33075377
  8. 8

    Neurologic Manifestations of Primary Sjögren Syndrome.

    Margaretten M

    Rheumatic diseases clinics of North America 2017; (43(4)):519-529 doi:10.1016/j.rdc.2017.06.002.

    PMID: 29061239
  9. 9

    Sjögren's Syndrome Associated with Fanconi's Syndrome and Osteomalacia.

    Gutierrez JO, Zurita MF, Zurita LA

    The American journal of case reports 2018; (19()):392-396 doi:10.12659/ajcr.907503.

    PMID: 29610453
  10. 10

    Pulmonary manifestations of Sjögren's syndrome.

    Flament T, Bigot A, Chaigne B, et al.

    European respiratory review : an official journal of the European Respiratory Society 2016; (25(140)):110-23 doi:10.1183/16000617.0011-2016.

    PMID: 27246587
  11. 11

    Association between comorbidities and extraglandular manifestations in primary Sjögren's syndrome: a multicenter cross-sectional study.

    Zhang Y, Li M, Zhang L, et al.

    Clinical rheumatology 2020; (39(9)):2677-2688 doi:10.1007/s10067-020-04992-x.

    PMID: 32146615
  12. 12

    Renal disorders in rheumatologic diseases: the spectrum is changing (Part 1: connective tissue diseases).

    Ponticelli C, Doria A, Moroni G

    Journal of nephrology 2021; (34(4)):1069-1080 doi:10.1007/s40620-020-00772-7.

    PMID: 32529559

This page explains the use of prednisone in Sjögren's syndrome for educational purposes only. Always consult your rheumatologist before starting, changing, or safely tapering any corticosteroid medications.

Stay up to date

Get notified when new research about Primary Sjögren's Syndrome is published.

No spam. Unsubscribe anytime.